Trilogy Capital’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.94M Sell
19,845
-118
-0.6% -$19.2K 0.11% 140
2026
Q2
$3.76M Sell
19,963
-134
-0.7% -$23.8K 0.15% 117
2026
Q1
$3.34M Sell
20,097
-1,142
-5% -$204K 0.15% 111
2025
Q4
$3.41M Sell
21,239
-7,722
-27% -$1.14M 0.15% 113
2025
Q3
$3.83M Sell
28,961
-1,818
-6% -$213K 0.18% 84
2025
Q2
$2.95M Buy
+30,779
New +$2.88M 0.14% 108

Other funds holding CHRW

Trilogy Capital's CHRW Position: Q3 2026 in Review

Trilogy Capital reduced its C.H. Robinson (CHRW) stake by 0.59% in Q3 2026, selling an estimated $19.2K and leaving 19,845 shares worth $2.94M. The position accounts for 0.11% of the portfolio, ranked #140.

Trilogy Capital first reported a position in CHRW in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.83M in Q3 2025. 123 funds tracked by Wall St. Rank hold CHRW as of Q3 2026.

  • Trilogy Capital held 19,845 shares of C.H. Robinson worth $2.94M as of Q3 2026.
  • Trilogy Capital sold 118 C.H. Robinson shares in Q3 2026, an estimated $19.2K.
  • C.H. Robinson made up 0.11% of Trilogy Capital's portfolio in Q3 2026, its #140 holding.
  • Trilogy Capital first reported a position in C.H. Robinson in Q2 2025 and has held it in 6 quarters since.
  • Trilogy Capital's C.H. Robinson position peaked at $3.83M in Q3 2025.
  • 123 funds tracked by Wall St. Rank held C.H. Robinson as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.